GSK raises 2025 sales forecast after strong growth in specialty medicines
PositiveFinancial Markets

GSK has raised its sales forecast for 2025 following impressive growth in its specialty medicines division. This positive development highlights the company's strong performance and potential for future success in the pharmaceutical market, particularly as demand for specialized treatments continues to rise.
— Curated by the World Pulse Now AI Editorial System









